Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard N Channick

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
American Journal of Respiratory and Critical Care Medicine|March 19, 2024
Pulmonary Hypertension in Idiopathic Interstitial Pneumonia Is Associated with Small Vessel PruningEileen M Harder, Fereidoun Abtin, Pietro Nardelli, et al.
Journal of the American College of Cardiology|May 1, 2010
Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trialVallerie V McLaughlin, Raymond L Benza, Lewis J Rubin, et al.
The American Journal of Medicine|April 6, 2016
Monitoring for Pulmonary Hypertension Following Pulmonary Embolism: The INFORM StudyVictor F Tapson, David M Platt, Fang Xia, et al.
The European Respiratory Journal|December 15, 2018
Risk stratification and medical therapy of pulmonary arterial hypertensionNazzareno Galiè, Richard N Channick, Robert P Frantz, et al.
American Journal of Respiratory and Critical Care Medicine|September 2, 2006
Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertensionVallerie V McLaughlin, Ronald J Oudiz, Adaani Frost, et al.
American Journal of Respiratory and Critical Care Medicine|September 23, 2021
Evolution of Obstructive Lung Function in Advanced Pulmonary Arterial HypertensionFarbod N Rahaghi, Megan Trieu, Faisal Shaikh, et al.
The European Respiratory Journal|June 27, 2015
Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertensionVallerie McLaughlin, Richard N Channick, Hossein-Ardeschir Ghofrani, et al.
Transplantation Direct|July 20, 2019
Portopulmonary Hypertension: A Survey of Practice Patterns and Provider AttitudesHilary M DuBrock, Reena J Salgia, Norman L Sussman, et al.
Circulation. Cardiovascular Imaging|May 16, 2015
Leaflet area as a determinant of tricuspid regurgitation severity in patients with pulmonary hypertensionJonathan Afilalo, Julia Grapsa, Petros Nihoyannopoulos, et al.
Transplantation|February 17, 2017
Predictors of Waitlist Mortality in Portopulmonary HypertensionHilary M DuBrock, David S Goldberg, Norman L Sussman, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
American Journal of Respiratory and Critical Care Medicine|March 19, 2024
Pulmonary Hypertension in Idiopathic Interstitial Pneumonia Is Associated with Small Vessel PruningEileen M Harder, Fereidoun Abtin, Pietro Nardelli, et al.
Journal of the American College of Cardiology|May 1, 2010
Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trialVallerie V McLaughlin, Raymond L Benza, Lewis J Rubin, et al.
The American Journal of Medicine|April 6, 2016
Monitoring for Pulmonary Hypertension Following Pulmonary Embolism: The INFORM StudyVictor F Tapson, David M Platt, Fang Xia, et al.
The European Respiratory Journal|December 15, 2018
Risk stratification and medical therapy of pulmonary arterial hypertensionNazzareno Galiè, Richard N Channick, Robert P Frantz, et al.
American Journal of Respiratory and Critical Care Medicine|September 2, 2006
Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertensionVallerie V McLaughlin, Ronald J Oudiz, Adaani Frost, et al.
American Journal of Respiratory and Critical Care Medicine|September 23, 2021
Evolution of Obstructive Lung Function in Advanced Pulmonary Arterial HypertensionFarbod N Rahaghi, Megan Trieu, Faisal Shaikh, et al.
The European Respiratory Journal|June 27, 2015
Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertensionVallerie McLaughlin, Richard N Channick, Hossein-Ardeschir Ghofrani, et al.
Transplantation Direct|July 20, 2019
Portopulmonary Hypertension: A Survey of Practice Patterns and Provider AttitudesHilary M DuBrock, Reena J Salgia, Norman L Sussman, et al.
Circulation. Cardiovascular Imaging|May 16, 2015
Leaflet area as a determinant of tricuspid regurgitation severity in patients with pulmonary hypertensionJonathan Afilalo, Julia Grapsa, Petros Nihoyannopoulos, et al.
Transplantation|February 17, 2017
Predictors of Waitlist Mortality in Portopulmonary HypertensionHilary M DuBrock, David S Goldberg, Norman L Sussman, et al.
Pageof 11